Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide + R-CHOP in Double-Expressor DLBCL
NCT04164368Phase 2Completed
- Sponsor
- Fudan University
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by Fudan University. Started Oct 2019; status: completed.
02
Drugs
lenalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT04164368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04164368.